None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Yongin Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 19 years of age or older 2. Clinical evidence of coronary artery disease including asymptomatic ischemia, stable angina, and acute coronary syndrome (an unstable angina, non-ST segmental ascending myocardial infarction, ST segmental ascending myocardial infarction) 3. Coronary lesion length greater than 30 mm 4. Voluntary written consent to participate in this clinical study
Exclusion criteria
Exclusion criteria: 1. Life expectancy within one year 2. Subjects with known intolerance or contraindications for the following drugs or substances: heparin, aspirin, clopidogrel, prashgrel, ticagreler 3. If other researchers decide that they are unsuitable for participation in this study (pregnant women, the elderly, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of one-year target lesion failure (a combination of cardiac death, target vascular myocardial infarction, and ischemic-induced target lesion re-perfusion) | — |
Secondary
| Measure | Time frame |
|---|---|
| One-year major cardiac adverse events (complex variables of death, myocardial infarction, stent thrombosis, and targeted lesion perfusion);a one-year incidence of heart death;1-year incidence of non-heart death;1-year target cardiomyopathy incidence;1-year incidence of non-targeted cardiomyopathy;Acute stent thrombosis within 24 hours, subacute stent thrombosis within 30 days, and incidence of late stent thrombosis in year 1;1 Year Ischemia-Induced Target Lesions Recurrent;1-year ischemic target lesion re-perfusion;a one-year stroke;Major bleeding rates per year (Bleeding Academic Research Consortium 3-5);For those who have performed 46mm Cre8 stent, whether or not overexpansion through OCT is achieved through OCT;In patients with acute myocardial infarction, the primary/secondary effectiveness of antiplatelet drugs is re-evaluated (clopidogrel vs prasugrel vs ticagrel on acute myocardial infraction) | — |
Countries
Korea, Republic of
Contacts
Public ContactDeokKyu Cho
Yonsei University Yongin Severance Hospital
Outcome results
None listed